BCTX

Briacell Therapeutics Corp. Common Shares

3.95

USD

+0.68

+20.80%

Nov 06, 15:59 UTC -5

Closed

After-Market

3.98

+0.03

+0.73%

Briacell Therapeutics Corp. Common Shares (BCTX) Earnings

BCTX Earnings Reports

Positive Surprise Ratio

BCTX beat 8 of 16 last estimates.

50%

Next Report

Date of Next Report

Dec 09, 2026

Estimate for Q1 27 (Revenue/ EPS)

Implied change from Q4 26 (Revenue/ EPS)

Implied change from Q1 26 (Revenue/ EPS)

Briacell Therapeutics Corp. Common Shares earnings per share and revenue

On Oct 14, 2026, BCTX reported earnings of -- USD per share (EPS) for Q4 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q1 27, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

INmune Bio Inc. Common stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.14

Actual

-$0.17

Surprise

-13.64%

Moderna, Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$1.27

Actual

$0.38

Surprise

+129.79%

Vera Therapeutics, Inc. Class A Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$1.65

Actual

-$1.30

Surprise

+21.33%

Novavax Inc

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.34

Actual

-$0.19

Surprise

+44.56%

Eton Pharmaceutcials, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.31

Actual

$1.06

Surprise

+232.50%

Castle Biosciences, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.37

Actual

-$0.13

Surprise

+65.32%

Monte Rosa Therapeutics, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.29

Actual

$0.03

Surprise

+110.09%

PUMA BIOTECHNOLOGY INC

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.09

Actual

$0.15

Surprise

+63.40%

Allogene Therapeutics, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.15

Actual

-$0.15

Surprise

+0.33%

Arcturus Therapeutics Holdings Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.69

Actual

-$0.26

Surprise

+62.44%

FAQ

What were Briacell Therapeutics Corp. Common Shares's earnings and revenue for the latest quarter Q4 2026?

For Q4 2026, Briacell Therapeutics Corp. Common Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Briacell Therapeutics Corp. Common Shares's Q4 2026 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Briacell Therapeutics Corp. Common Shares expected to report next?

The next earning report is scheduled for Dec 09, 2026.

What are the forecasts for Briacell Therapeutics Corp. Common Shares's next earnings report?

Based on -- analysts, Briacell Therapeutics Corp. Common Shares is expected to report EPS of -- and revenue of -- for Q1 2027.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.